Skip to content

Longitudinal Interaction Between APOA5 -1131T>C and Overweight Accelerates Arterial Stiffness

Longitudinal Interaction Between APOA5 -1131T>C and Overweight

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03367598
Enrollment
503
Registered
2017-12-08
Start date
2008-01-01
Completion date
2013-12-31
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Brief summary

The aim of this study is to evaluate whether the longitudinal interaction between APOA5 -1131C variants and overweight could accelerate age-related increases in arterial stiffness and circulating triglycerides in healthy subjects.

Interventions

GENETICrs662799 (APOA5 -1131T>C)

Among the 349 normal-weight individuals, 168 were homozygous (TT) for the T allele, 155 were heterozygous for the C allele (TC) and 26 were homozygous (CC) for the C allele of the APOA5 -1131T\>C polymorphism. Among the 154 overweight individuals, 68 were homozygous (TT) for the T allele, 75 were heterozygous for the C allele (TC) and 11 were homozygous (CC) for the C allele of the APOA5 -1131T\>C polymorphism.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Nondiabetic (fasting serum glucose concentration \< 126 mg/dL) * Nonobese (BMI ≥ 25 kg/m2)

Exclusion criteria

* Current and/or past history of cardiovascular disease * Diabetes mellitus (fasting glucose levels ≥126 mg/dL) * Abnormal liver or renal function * Thyroid or pituitary disease * Pregnancy or lactation * Regular use of any medication

Design outcomes

Primary

MeasureTime frameDescription
Brachial-ankle PWV (baPWV)at baselinecm/s

Secondary

MeasureTime frameDescription
Triglycerideat baselinemg/dL

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026